文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

早期预警评分评估COVID-19患者危重症概率

Early warning scores to assess the probability of critical illness in patients with COVID-19.
PubMed 文献 · Emerg Med J · 2021-10-27
一句话结论NEWS2≥6和q-COVID评分≥3预测COVID-19患者24小时内入ICU性能仅fair(AUC 0.740/0.760),不足以单独决策。

多中心研究纳入9家医院1501例确诊SARS-CoV-2感染且需住院、有完整复苏医嘱的急诊患者,评估早期预警评分(EWS)预测24小时内因高流量氧疗或机械通气入ICU的性能。NEWS2≥6和q-COVID评分≥3优于其他评分,AUC分别为0.740(95%CI 0.696-0.783)和0.760(95%CI 0.712-0.800),敏感性78.1%/75.9%,特异性56.3%/61.8%。但诊断性能仅fair,作者结论不能临床用于充分预测24小时内ICU入住需求。

要点

  • NEWS2≥6预测COVID-19急诊患者24小时内入ICU:敏感性78.1%、特异性56.3%,AUC 0.740(95%CI 0.696-0.783)。
  • q-COVID评分≥3预测同一终点:敏感性75.9%、特异性61.8%,AUC 0.760(95%CI 0.712-0.800)。
  • NEWS2≥6与q-COVID评分优于其他研究的临床风险评分,但诊断性能仅fair,不能单独用于充分预测24小时内ICU入住。
  • ICU患者较非ICU患者外周血氧饱和度更低(86.7% vs 93.7%,p≤0.001),BMI更高(29.2 vs 27.9,p=0.043)。
  • 研究纳入1501例,13.1%在急诊后24小时内入ICU,86.9%入普通病房。

适用人群与场景

  • 9家医院急诊科收治、确诊SARS-CoV-2感染、有完整复苏医嘱且需住院的成人患者,纳入时间2020年2月27日至7月30日。
  • 中位年龄71岁(范围19-99岁),男性60.3%。

诊断标准与关键阈值

  • NEWS2≥6为预测24小时内入ICU的阈值,敏感性78.1%、特异性56.3%。
  • q-COVID评分≥3为预测24小时内入ICU的阈值,敏感性75.9%、特异性61.8%。
  • 主要结局为急诊就诊后24小时内因高流量氧疗或机械通气需入ICU。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心研究,9家医院,1501例确诊SARS-CoV-2感染且需住院的急诊患者;主要终点为24小时内入ICU。
  • 13.1%患者24小时内入ICU,86.9%入普通病房。
  • ICU患者外周血氧饱和度86.7% vs 非ICU 93.7%(p≤0.001),BMI 29.2 vs 27.9(p=0.043)。
  • NEWS2≥6预测24小时内入ICU的AUC 0.740(95%CI 0.696-0.783),敏感性78.1%,特异性56.3%。
  • q-COVID评分≥3预测24小时内入ICU的AUC 0.760(95%CI 0.712-0.800),敏感性75.9%,特异性61.8%。
  • NEWS2≥6和q-COVID评分优于所有其他研究的临床风险评分,但诊断性能仅fair。

证据类型、等级与局限

  • 多中心队列研究(原文称multicentre study),样本量1501例,9家医院。
  • 局限:诊断性能仅fair(AUC 0.740/0.760),作者结论不能临床用于充分预测24小时内ICU入住需求。

对床旁实践的改变

  • NEWS2≥6或q-COVID评分≥3可提示COVID-19急诊患者24小时内入ICU风险较高,但敏感性78.1%/75.9%、特异性56.3%/61.8%,不能单独作为ICU入住决策依据。
  • 不能因评分低于阈值而排除24小时内需入ICU的可能;原文结论明确这些模型不能临床用于充分预测。
  • 原文未提供其他适用或不适用人群、常见陷阱的具体说明。

指南或共识出处

  • Emerg Med J(原文未提供具体指南或共识名称)

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: Validated clinical risk scores are needed to identify patients with COVID-19 at risk of severe disease and to guide triage decision-making during the COVID-19 pandemic. The objective of the current study was to evaluate the performance of early warning scores (EWS) in the ED when identifying patients with COVID-19 who will require intensive care unit (ICU) admission for high-flow-oxygen usage or mechanical ventilation.

METHODS: Patients with a proven SARS-CoV-2 infection with complete resuscitate orders treated in nine hospitals between 27 February and 30 July 2020 needing hospital admission were included. Primary outcome was the performance of EWS in identifying patients needing ICU admission within 24 hours after ED presentation.

RESULTS: In total, 1501 patients were included. Median age was 71 (range 19-99) years and 60.3% were male. Of all patients, 86.9% were admitted to the general ward and 13.1% to the ICU within 24 hours after ED admission. ICU patients had lower peripheral oxygen saturation (86.7% vs 93.7, p≤0.001) and had a higher body mass index (29.2 vs 27.9 p=0.043) compared with non-ICU patients. National Early Warning Score 2 (NEWS2) ≥ 6 and q-COVID Score were superior to all other studied clinical risk scores in predicting ICU admission with a fair area under the receiver operating characteristics curve of 0.740 (95% CI 0.696 to 0.783) and 0.760 (95% CI 0.712 to 0.800), respectively. NEWS2 ≥6 and q-COVID Score ≥3 discriminated patients admitted to the ICU with a sensitivity of 78.1% and 75.9%, and specificity of 56.3% and 61.8%, respectively.

CONCLUSION: In this multicentre study, the best performing models to predict ICU admittance were the NEWS2 and the Quick COVID-19 Severity Index Score, with fair diagnostic performance. However, due to the moderate performance, these models cannot be clinically used to adequately predict the need for ICU admission within 24 hours in patients with SARS-CoV-2 infection presenting at the ED.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Veldhuis L, Ridderikhof ML, Schinkel M, et al. Early warning scores to assess the probability of critical illness in patients with COVID-19. Emerg Med J. 2021. PMID: 34706897. doi:10.1136/emermed-2020-211054

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。